Table 3.

Clinicopathological variables according to EBV status. Stage, subtype and symptoms were defined following review. Interquartile range (IQR).

	EBV+ (n = 62)	EBV− (n = 104)	p-Value
Age at diagnosis			<0.001
Median, IQR	10.0 (7.1–13.8)	14.2 (12.2–15.3)
Gender			0.067
Male	44 (71.0%)	59 (56.7%)
Female	18 (29.0%)	45 (43.3%)
Subtype			0.005
Nodular sclerosing	41 (66.1%)	85 (81.7%)
Mixed cellularity	17 (27.4%)	9 (8.7%)
Other/unknown	4 (6.5%)	10 (9.6%)
Stage			0.027
I	8 (12.9%)	5 (4.8%)
II	29 (46.8%)	48 (46.2%)
III	18 (29.0%)	22 (21.2%)
IV	7 (11.3%)	29 (27.9%)
Symptoms			0.897
A	37 (59.7%)	61 (58.7%)
B	25 (40.3%)	43 (41.3%)